Developer docs
API playgroundTry for free, no card

Search company profiles

Pathogenus Consulting

Full company profile

uuid00srylg

Namestring
Pathogenus Consulting
Legal namestring
PATHOGENUS CONSULTING LTD.
Websiteurl
pathogenus.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Pathogenus Consulting Ltd. is a UK-registered private limited consultancy (company number 16206861) that provides specialized advisory services for infectious disease drug and vaccine development. The firm is organized around six integrated service pillars: Clinical Trial Design, Regulatory Affairs, Clinical Oversight and Safety Monitoring, Project and Program Management, Team Leadership and Corporate Efficiencies, and Scientific Advice and Analyses. Its offering spans the development lifecycle from R&D through market authorization, including regulatory interactions with FDA, EMA, TGA, and MHRA, and access to accelerated pathways such as Orphan Drug Designation, Fast Track, PRIME, and ILAP. Documented engagements include Controlled Human Infection study data review, RCT data reanalysis enabling positive investor announcements, and Human Challenge Trial design for cholera and other indications.

The firm serves biotechnology and pharmaceutical companies ranging from start-up biotechs to large pharma, alongside clinical research organizations (CROs) requiring infectious disease operational support. Documented clients include a clinical-stage pharmaceutical company, an Australian intranasal drug developer, a Portuguese diabetic foot ulcer therapeutics firm, and a cholera vaccine developer. Services are delivered through direct engagement by senior team members rather than junior staffing pyramids, positioning the firm as a boutique senior-advisory practice rather than a staffing-led consultancy.

Pathogenus operates a sales-led B2B model with quote-based pricing determined by scope and complexity, generating revenue solely from professional services fees. The firm is led by founder Adrian Wildfire (35+ years in infectious diseases) alongside five other senior professionals with backgrounds at Roche, large CROs, and academic referral hospitals, supported by offices in London, Brussels, Basel, and Amsterdam. The company evolved from the prior iterations CHIMunomics and CHIMagents Ltd. and currently maintains a strategic partnership with US-based Southern Research signed in February 2026. No institutional investors, parent company, or public market presence is evidenced.

Short descriptiontext

Pathogenus Consulting Ltd. provides infectious disease drug and vaccine development consulting — including clinical trial design, regulatory affairs, safety monitoring, and program management — to biotechnology and pharmaceutical companies via senior industry experts across four European offices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
infectious disease consulting, clinical trial design, regulatory affairs consulting, drug development advisory, vaccine development consulting
Industry2 codes
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code2 codes
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical & Life Sciences Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

Professional consulting services delivered by former industry leaders and executives, providing expertise in project management, operational and change management, scientific and clinical guidance, and analyses for drug and vaccine development across all stages from R&D to market authorisation.

pathogenus.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pathogenus Consulting provides expert consulting services for drug and vaccine development, with a specialisation in infectious diseases. Services span clinical trial design, regulatory affairs, clinical oversight and safety monitoring, project and program management, team leadership and corporate efficiencies, and scientific advice and analyses. The firm supports clients across the full development lifecycle from R&D to market authorisation, drawing on former pharma and CRO industry leaders to deliver strategic and operational guidance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Clinical program rescued from near-abortion due to safety finding; attribution clarified as co-medication rather than study drug, enabling program continuation
+2 more records
Product overview1 text field

Pathogenus Consulting Ltd. offers a unified suite of consultancy services for drug and vaccine development, providing integrated support across the development lifecycle from R&D to market authorisation. The portfolio encompasses Clinical Trial Design Services, Regulatory Affairs Services, Clinical Oversight and Safety Monitoring Services, Project and Program Management Services, Team Leadership and Corporate Efficiencies Services, and Scientific Advice and Analyses Services. These services work together as an integrated consultancy offering, with specialists available for project management, operational and change management, scientific and clinical guidance and analyses, enabling clients to navigate complex development programs and regulatory environments.

Product and service6 records
1Clinical Trial Design Services
CategoryConsulting - Clinical Development
Description

Expert guidance on clinical trial design including recommendation of appropriate trial designs (conventional, group-sequential, adaptive, biomarker-based), advice on selection of endpoints and objectives, and optimised interim decisions including stopping rules and sample-size re-estimation. Intended for biotech and pharmaceutical sponsors designing infectious disease clinical studies.

2Regulatory Affairs Services
CategoryConsulting - Regulatory Affairs
Description

Integrated regulatory strategy consulting for global product development, including interactions with EMA, FDA, TGA, and other regulatory authorities, access to Orphan Drug Designations, and accelerated development pathways such as Fast Track, PRIME, and ILAP. Targeted at biotech and pharma sponsors navigating complex regulatory environments.

3Clinical Oversight and Safety Monitoring Services
CategoryConsulting - Clinical Oversight
Description

Expert clinical development oversight including design and implementation of clinical studies (Phases I-IV), expertise in virology and respiratory infections, anti-infective safety assessments, medical evaluation of assets, pharmacovigilance, and epidemiological study design and analysis. Serves sponsors needing senior medical and safety oversight.

4Project and Program Management Services
CategoryConsulting - Project Management
Description

Life sciences project management including project planning, execution, risk management, resource management, regulatory compliance, change management, quality assurance, capital/site facility build projects, clinical development management, manufacturing, and technology transfer. Supports sponsors running complex multi-stage development programs.

5Team Leadership and Corporate Efficiencies Services
CategoryConsulting - Organisational Leadership
Description

Building high-performance international leadership teams, divisional and project teams including KOLs, scientists, regulatory, HR, legal, compliance, QA, and operations associates; business development, operational efficiency optimisation, and strategic alliances management. Targets biotech and pharma sponsors needing senior team build-out or operational improvements.

6Scientific Advice and Analyses Services
CategoryConsulting - Scientific Advisory
Description

Independent expert advice in translational sciences, defining Mechanism(s) of Action and Efficacy, assay selection and validation guidance, and assistance in interpreting pre-clinical and clinical datasets for regulatory compliance. Aimed at biotech and pharma sponsors needing expert scientific interpretation of their data.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-02
Description

Southern Research and Pathogenus Consulting Ltd. (PCL) signed a partnership agreement on 02-Feb-2026. The partnership combines Southern Research's research capabilities with Pathogenus's infectious disease expertise to deliver enhanced clinical development services to clients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large global CRO providing clinical trial design and execution services across therapeutic areas including infectious disease; comparable as a competing provider of clinical development services to biotech and pharma clients.

TypeBroad incumbent
Description

Mid-sized global CRO offering full-service clinical development across therapeutic areas; competes with Pathogenus in clinical trial design and execution for biotech and pharma sponsors.

3KCR
TypeEmerging player
Description

European-headquartered CRO with cross-region clinical development services; comparable as a smaller, regionally-focused peer competing with Pathogenus for European biotech and pharma engagements.

TypeBroad incumbent
Description

Global mid-sized CRO with strong presence in infectious disease and vaccine trials, including human challenge studies; serves as a comparable provider of clinical and regulatory services in the ID space.

TypeBroad incumbent
Description

Large global CRO with deep clinical development, regulatory affairs and biopharmaceutical services capabilities; serves as a broad incumbent alternative for biotech/pharma seeking clinical and regulatory support.

TypeEmerging player
Description

UK-based specialty clinical research organization with Phase I expertise and early-phase trial capabilities; overlaps with Pathogenus's infectious disease clinical design and oversight services in a similar UK base.

TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical through clinical development services with growing infectious disease and vaccine capabilities; competes with Pathogenus for integrated development mandates.

TypeBroad incumbent
Description

Global CRO with established infectious disease and vaccine development capabilities, including preclinical and clinical services; competes with Pathogenus for pharma and biotech development mandates.

TypeBroad incumbent
Description

World's largest CRO with broad clinical, regulatory and consulting capabilities including infectious disease R&D support; a major incumbent competitor in the clinical development services market Pathogenus addresses.

TypeDirect peer
Description

Specialty clinical services company focused on human challenge trials and infectious disease clinical research, closely aligned with Pathogenus's CHIM heritage and infectious disease specialty.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pathogenus Consulting

Pharmaceutical & Life Sciences Consultingpathogenus.com

Pathogenus Consulting Ltd. provides infectious disease drug and vaccine development consulting — including clinical trial design, regulatory affairs, safety monitoring, and program management — to biotechnology and pharmaceutical companies via senior industry experts across four European offices.

What Pathogenus Consulting does

Pathogenus Consulting Ltd. is a UK-registered private limited consultancy (company number 16206861) that provides specialized advisory services for infectious disease drug and vaccine development. The firm is organized around six integrated service pillars: Clinical Trial Design, Regulatory Affairs, Clinical Oversight and Safety Monitoring, Project and Program Management, Team Leadership and Corporate Efficiencies, and Scientific Advice and Analyses. Its offering spans the development lifecycle from R&D through market authorization, including regulatory interactions with FDA, EMA, TGA, and MHRA, and access to accelerated pathways such as Orphan Drug Designation, Fast Track, PRIME, and ILAP. Documented engagements include Controlled Human Infection study data review, RCT data reanalysis enabling positive investor announcements, and Human Challenge Trial design for cholera and other indications.

The firm serves biotechnology and pharmaceutical companies ranging from start-up biotechs to large pharma, alongside clinical research organizations (CROs) requiring infectious disease operational support. Documented clients include a clinical-stage pharmaceutical company, an Australian intranasal drug developer, a Portuguese diabetic foot ulcer therapeutics firm, and a cholera vaccine developer. Services are delivered through direct engagement by senior team members rather than junior staffing pyramids, positioning the firm as a boutique senior-advisory practice rather than a staffing-led consultancy.

Pathogenus operates a sales-led B2B model with quote-based pricing determined by scope and complexity, generating revenue solely from professional services fees. The firm is led by founder Adrian Wildfire (35+ years in infectious diseases) alongside five other senior professionals with backgrounds at Roche, large CROs, and academic referral hospitals, supported by offices in London, Brussels, Basel, and Amsterdam. The company evolved from the prior iterations CHIMunomics and CHIMagents Ltd. and currently maintains a strategic partnership with US-based Southern Research signed in February 2026. No institutional investors, parent company, or public market presence is evidenced.

Pathogenus Consulting firmographics

Firmographics
Name
Pathogenus Consulting
Legal name
PATHOGENUS CONSULTING LTD.
Website
https://pathogenus.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Pathogenus Consulting Ltd. provides infectious disease drug and vaccine development consulting — including clinical trial design, regulatory affairs, safety monitoring, and program management — to biotechnology and pharmaceutical companies via senior industry experts across four European offices.
Ownership category
akta.pro rank

Pathogenus Consulting industry classification

Industry
Product category
Pharmaceutical & Life Sciences Consulting
NAICS
Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Infectious disease consulting
  • Clinical trial design
  • Regulatory affairs consulting
  • Drug development advisory
  • Vaccine development consulting

Where Pathogenus Consulting is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Pathogenus Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Consulting Services: Professional consulting services delivered by former industry leaders and executives, providing expertise in project management, operational and change management, scientific and clinical guidance, and analyses for drug and vaccine development across all stages from R&D to market authorisation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Pathogenus Consulting product offering

Product offering

Core offering

Pathogenus Consulting provides expert consulting services for drug and vaccine development, with a specialisation in infectious diseases. Services span clinical trial design, regulatory affairs, clinical oversight and safety monitoring, project and program management, team leadership and corporate efficiencies, and scientific advice and analyses. The firm supports clients across the full development lifecycle from R&D to market authorisation, drawing on former pharma and CRO industry leaders to deliver strategic and operational guidance.

Product overview

Pathogenus Consulting Ltd. offers a unified suite of consultancy services for drug and vaccine development, providing integrated support across the development lifecycle from R&D to market authorisation. The portfolio encompasses Clinical Trial Design Services, Regulatory Affairs Services, Clinical Oversight and Safety Monitoring Services, Project and Program Management Services, Team Leadership and Corporate Efficiencies Services, and Scientific Advice and Analyses Services. These services work together as an integrated consultancy offering, with specialists available for project management, operational and change management, scientific and clinical guidance and analyses, enabling clients to navigate complex development programs and regulatory environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Design Services Expert guidance on clinical trial design including recommendation of appropriate trial designs (conventional, group-sequential, adaptive, biomarker-based), advice on selection of endpoints and objectives, and optimised interim decisions including stopping rules and sample-size re-estimation. Intended for biotech and pharmaceutical sponsors designing infectious disease clinical studies.
  • Regulatory Affairs Services Integrated regulatory strategy consulting for global product development, including interactions with EMA, FDA, TGA, and other regulatory authorities, access to Orphan Drug Designations, and accelerated development pathways such as Fast Track, PRIME, and ILAP. Targeted at biotech and pharma sponsors navigating complex regulatory environments.
  • Clinical Oversight and Safety Monitoring Services Expert clinical development oversight including design and implementation of clinical studies (Phases I-IV), expertise in virology and respiratory infections, anti-infective safety assessments, medical evaluation of assets, pharmacovigilance, and epidemiological study design and analysis. Serves sponsors needing senior medical and safety oversight.
  • Project and Program Management Services Life sciences project management including project planning, execution, risk management, resource management, regulatory compliance, change management, quality assurance, capital/site facility build projects, clinical development management, manufacturing, and technology transfer. Supports sponsors running complex multi-stage development programs.
  • Team Leadership and Corporate Efficiencies Services Building high-performance international leadership teams, divisional and project teams including KOLs, scientists, regulatory, HR, legal, compliance, QA, and operations associates; business development, operational efficiency optimisation, and strategic alliances management. Targets biotech and pharma sponsors needing senior team build-out or operational improvements.
  • Scientific Advice and Analyses Services Independent expert advice in translational sciences, defining Mechanism(s) of Action and Efficacy, assay selection and validation guidance, and assistance in interpreting pre-clinical and clinical datasets for regulatory compliance. Aimed at biotech and pharma sponsors needing expert scientific interpretation of their data.

Quantifiable outcome

  • Clinical program rescued from near-abortion due to safety finding; attribution clarified as co-medication rather than study drug, enabling program continuation
  • +2 more outcomes

Companies that use Pathogenus Consulting

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Pathogenus Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pathogenus Consulting partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Southern ResearchcoreStrategic or Co-development Partner · 2 February 2026Southern Research and Pathogenus Consulting Ltd. (PCL) signed a partnership agreement on 02-Feb-2026. The partnership combines Southern Research's research capabilities with Pathogenus's infectious disease expertise to deliver enhanced clinical development services to clients.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Pathogenus Consulting competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: Large global CRO providing clinical trial design and execution services across therapeutic areas including infectious disease; comparable as a competing provider of clinical development services to biotech and pharma clients.
  • Medpace Holdings: Mid-sized global CRO offering full-service clinical development across therapeutic areas; competes with Pathogenus in clinical trial design and execution for biotech and pharma sponsors.
  • Worldwide Clinical Trials: Global mid-sized CRO with strong presence in infectious disease and vaccine trials, including human challenge studies; serves as a comparable provider of clinical and regulatory services in the ID space.
  • Parexel International: Large global CRO with deep clinical development, regulatory affairs and biopharmaceutical services capabilities; serves as a broad incumbent alternative for biotech/pharma seeking clinical and regulatory support.
  • Pharmaron: Global CRO/CDMO offering preclinical through clinical development services with growing infectious disease and vaccine capabilities; competes with Pathogenus for integrated development mandates.
  • Charles River Laboratories: Global CRO with established infectious disease and vaccine development capabilities, including preclinical and clinical services; competes with Pathogenus for pharma and biotech development mandates.
  • IQVIA: World's largest CRO with broad clinical, regulatory and consulting capabilities including infectious disease R&D support; a major incumbent competitor in the clinical development services market Pathogenus addresses.

Emerging players

  • KCR: European-headquartered CRO with cross-region clinical development services; comparable as a smaller, regionally-focused peer competing with Pathogenus for European biotech and pharma engagements.
  • Richmond Pharmacology: UK-based specialty clinical research organization with Phase I expertise and early-phase trial capabilities; overlaps with Pathogenus's infectious disease clinical design and oversight services in a similar UK base.

Direct peers

  • hVIVO plc: Specialty clinical services company focused on human challenge trials and infectious disease clinical research, closely aligned with Pathogenus's CHIM heritage and infectious disease specialty.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Pathogenus Consulting social profiles

Digital presence

Pathogenus Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pathogenus Consulting leadership team

Management profile

Number of profiles

Profiles6 records

Pathogenus Consulting funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pathogenus Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pathogenus Consulting

What does Pathogenus Consulting do?

Pathogenus Consulting provides expert consulting services for drug and vaccine development, with a specialisation in infectious diseases. Services span clinical trial design, regulatory affairs, clinical oversight and safety monitoring, project and program management, team leadership and corporate efficiencies, and scientific advice and analyses. The firm supports clients across the full development lifecycle from R&D to market authorisation, drawing on former pharma and CRO industry leaders to deliver strategic and operational guidance.

Is Pathogenus Consulting a public or private company?

Pathogenus Consulting is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pathogenus Consulting founded?

Pathogenus Consulting was founded in 2025. It employs 1 to 10 people.

Where is Pathogenus Consulting based?

Pathogenus Consulting is headquartered in London, United Kingdom, in the Europe region.

How does Pathogenus Consulting make money?

One revenue line is on record: consulting Services.

Who are Pathogenus Consulting's main competitors?

Broad incumbents on record are ICON plc, Medpace Holdings, Worldwide Clinical Trials, Parexel International, Pharmaron, Charles River Laboratories and IQVIA. Emerging players are KCR and Richmond Pharmacology. hVIVO plc is listed as a direct peer.

Does Pathogenus Consulting have an API?

No public API is recorded for Pathogenus Consulting.

What industry is Pathogenus Consulting in?

Pathogenus Consulting's product category is Pharmaceutical & Life Sciences Consulting. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals